Deva Holding AS
Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and … Read more
Deva Holding AS (DEVA) - Total Liabilities
Latest total liabilities as of September 2025: TL9.02 Billion TRY
Based on the latest financial reports, Deva Holding AS (DEVA) has total liabilities worth TL9.02 Billion TRY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Deva Holding AS - Total Liabilities Trend (2005–2024)
This chart illustrates how Deva Holding AS's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Deva Holding AS Competitors by Total Liabilities
The table below lists competitors of Deva Holding AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Geox S.p.A
PINK:GXSBF
|
USA | $594.19 Million |
|
Katahdin Bankshares Corp
OTCQX:KTHN
|
USA | $991.47 Million |
|
Actinogen Medical Limited
PINK:ATGGF
|
USA | $6.15 Million |
|
Ocean Power Technologies Inc
NYSE MKT:OPTT
|
USA | $17.02 Million |
|
Bogazici Beton Sanayi ve Ticaret AS
IS:BOBET
|
Turkey | TL5.89 Billion |
|
YHN Acquisition I Limited Ordinary Shares
NASDAQ:YHNA
|
USA | $1.94 Million |
|
flooidCX Corp
PINK:FLCX
|
USA | $4.10 Million |
Liability Composition Analysis (2005–2024)
This chart breaks down Deva Holding AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Deva Holding AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Deva Holding AS (2005–2024)
The table below shows the annual total liabilities of Deva Holding AS from 2005 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | TL8.92 Billion | -19.37% |
| 2023-12-31 | TL11.06 Billion | +135.96% |
| 2022-12-31 | TL4.69 Billion | +99.28% |
| 2021-12-31 | TL2.35 Billion | +61.82% |
| 2020-12-31 | TL1.45 Billion | +33.52% |
| 2019-12-31 | TL1.09 Billion | +18.07% |
| 2018-12-31 | TL922.03 Million | +41.56% |
| 2017-12-31 | TL651.32 Million | +29.06% |
| 2016-12-31 | TL504.68 Million | -6.51% |
| 2015-12-31 | TL539.84 Million | +12.09% |
| 2014-12-31 | TL481.62 Million | +13.70% |
| 2013-12-31 | TL423.58 Million | +22.91% |
| 2012-12-31 | TL344.63 Million | +7.09% |
| 2011-12-31 | TL321.81 Million | +13.72% |
| 2010-12-31 | TL282.98 Million | +26.74% |
| 2009-12-31 | TL223.27 Million | -4.69% |
| 2008-12-31 | TL234.25 Million | +99.57% |
| 2007-12-31 | TL117.38 Million | +15.72% |
| 2006-12-31 | TL101.43 Million | -36.08% |
| 2005-12-31 | TL158.68 Million | -- |